Tumor Infiltrating Lymphocyte Expression of PD-1 Predicts Response to Anti-PD-1/PD-L1 Immunotherapy

por Bevins, Nicholas J., Okamura, Ryosuke, Montesion, Meagan, Adashek, Jacob J., Goodman, Aaron M., Kurzrock, Razelle
Publicado 2022

SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses

por Suhandynata, Raymond T., Bevins, Nicholas J., Tran, Jenny T., Huang, Deli, Hoffman, Melissa A., Lund, Kyle, Kelner, Michael J., McLawhon, Ronald W., Gonias, Steven L., Nemazee, David, Fitzgerald, Robert L.
Publicado 2021

SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses

por Suhandynata, Raymond T, Bevins, Nicholas J, Tran, Jenny T, Huang, Deli, Hoffman, Melissa A, Lund, Kyle, Kelner, Michael J, McLawhon, Ronald W, Gonias, Steven L, Nemazee, David, Fitzgerald, Robert L
Publicado 2021

T-cell priming transcriptomic markers: implications of immunome heterogeneity for precision immunotherapy

por Miyashita, Hirotaka, Kurzrock, Razelle, Bevins, Nicholas J., Thangathurai, Kartheeswaran, Lee, Suzanna, Pabla, Sarabjot, Nesline, Mary, Glenn, Sean T., Conroy, Jeffrey M., DePietro, Paul, Rubin, Eitan, Sicklick, Jason K., Kato, Shumei
Publicado 2023